Philips has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Verida spectral CT system.
Validated biomarkers help physicians identify patients that will benefit most from certain treatments, but implementation challenges remain.
Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.
Avanos Medical is to be acquired by affiliates of AIP in an all-cash transaction that values the company at an enterprise value of $1.27bn.
J&J has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety of its Varipulse PFA platform in first-time users.
Phantom Neuro has secured approval to initiate a trial of its minimally invasive muscle-machine interface in Australia.
Boston Scientific shared the results during a late-breaking presentation at this year’s EHRA congress in Paris, France.
ProSomnus Sleep Technologies has received the US Food and Drug Administration (FDA) Class II 510(k) clearance for its RPMO₂ OSA device.
The device is designed to facilitate safe and reproducible left-heart access. Credit: MMD Creative / Shutterstock.com. Protaryx Medical has received the US Food and Drug Administration (FDA) 510(k) ...
Heartflow alleges that after working as its consultant, Cleerly’s CEO launched a competing enterprise “built upon” Heartflow’s innovations.
GE HealthCare offers a modular cloud-based suite integrating into current breast imaging operations. Credit: ORION PRODUCTION / Shutterstock.com. GE HealthCare has expanded its partnership with RadNet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results